Gene Therapy - Table of Contents alert Volume 25 Issue 2

If you are unable to see the message below, click here to view.

Advertisement Analyze biomolecular interactions using AAV biosensors Prepackaged and Ready-to-use Growing collection of sensors (e.g. Calcium and glutamate) CaMPARI, GCaMP3, GCaMP5, GCaMP6, jRCaMP1, jRGECO1 & iGLuSnFR Choice of promoter and the ability to include Cre inducible (FLEx-ON) expression. Perfect for in vitro or in vivo models. Learn more   TABLE OF CONTENTS Volume 25, Issue 2 In this issue Comment Article Brief Communication Also new AOP   Advertisement nature.com webcasts Nature Research Custom presents a webcast on: MicroRNAs in CSF as prodromal biomarkers for Huntington's disease   Date: Tuesday, May 29, 2018   Join our webcast to learn about the fundamental characteristics of microRNAs and why Huntington's disease may serve as a disease model for the assessment of biomarkers.   This webcast has been produced on behalf of the sponsor who retains sole responsibility for content   Register for FREE    Sponsored by: HTG Molecular  Comment Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review Prasanthi Sampara, Rajkiran Reddy Banala, Satish Kumar Vemuri, Gurava Reddy AV & Subbaiah GPV Gene Therapy 2018 25 :67 - 82; March 22, 2018; 10.1038/s41434-018-0004-0   Abstract | Full Text Article Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector Melvin Y. Rincon, Filip de Vin, Sandra I. Duqué, Shelly Fripont, Stephanie A. Castaldo et al. Gene Therapy 2018 25 :83 - 92; March 09, 2018; 10.1038/s41434-018-0005-z   Abstract | Full Text Brief Communication Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters C. Burkart, A. Mukhopadhyay, S. A. Shirley, R. J. Connolly, J. H. Wright et al. Gene Therapy 2018 25 :93 - 103; March 09, 2018; 10.1038/s41434-018-0006-y   Abstract | Full Text MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates Alan H. Nagahara, Bayard R. Wilson, Iryna Ivasyk, Imre Kovacs, Saytam Rawalji et al. Gene Therapy 2018 25 :104 - 114; March 13, 2018; 10.1038/s41434-018-0010-2   Abstract | Full Text Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma Bijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, Ritu Shrestha, Charmaine A. Ramlogan-Steel et al. Gene Therapy 2018 25 :115 - 128; March 21, 2018; 10.1038/s41434-018-0002-2   Abstract | Full Text AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model Mehmet E. Yalvac, Jakkrit Amornvit, Lei Chen, Kimberly M. Shontz, Sarah Lewis et al. Gene Therapy 2018 25 :129 - 138; March 09, 2018; 10.1038/s41434-018-0009-8   Abstract | Full Text Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9 Calvin J. Stephens, Elena Kashentseva, William Everett, Lyudmila Kaliberova & David T. Curiel Gene Therapy 2018 25 :139 - 156; March 27, 2018; 10.1038/s41434-018-0003-1   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.